Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Tumor control and survival have improved with the use of radiotherapy (RT) plus concomitant and adjuvant chemotherapy, but the prognosis remain poor. In most cases the recurrence occurs within 7–9 months after...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciammella, Patrizia, Podgornii, Ala, Galeandro, Maria, D’Abbiero, Nunziata, Pisanello, Anna, Botti, Andrea, Cagni, Elisabetta, Iori, Mauro, Iotti, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852333/
https://www.ncbi.nlm.nih.gov/pubmed/24066926
http://dx.doi.org/10.1186/1748-717X-8-222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852333/
https://www.ncbi.nlm.nih.gov/pubmed/24066926
http://dx.doi.org/10.1186/1748-717X-8-222

Ejemplares similares